Giovanni Mogna

This inventor holds 32 USPTO granted patents and 37 published patent applications, plus 7 CIPO patents and 52 EPO patents, primarily in Probiotic Bacterial Compositions. Top assignees: Probiotical S.p.a., Probiotical North America Inc., Alce North America, Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giovanni Mogna. Retrieved from https://idiyas.com/inventor/giovanni-mogna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 37)

% Patents Active = 75.0

CIPO Patents = 7 (Patent Applications = 23)

EPO Patents = 52 (Patent Applications = 55)

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 156(Granted Patents)

Company Filing History:

Probiotical North America Inc.

patents

2 out of 2

Alce North America, Inc.

5. 3 out of 834,513

Other

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Probiotic Bacteria

Lactic Acid Bacteria

Immune Disorders

Tumor Treatment

Vaginal Infections

Infant Food

Hypercholesterolaemia

Acne Treatment

Melatonin Compositions

Dietetic Composition

Gastroprotected Lysozyme

Cystitis Treatment

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343363 - Lactic acid bacterial composition for the treatment of bacterial vaginal infections byand, if present, of concurrent fungal infections (2025-07-01),

2. 11969449 - Composition for use in the treatment of major depressive disorder (2024-04-30),

3. 11628193 - Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne (2023-04-18),

4. 11446340 - Probiotic bacterial strains and symbiotic composition containing the same intended for infant food (2022-09-20),

5. 11298384 - Composition for use in the treatment of major depressive disorder (2022-04-12),

6. 11191792 - Bacterial composition for use in attenuating the decline in performance after exercise (2021-12-07),

7. 11178880 - Production of a yeast-free, highly digestible pizza by using a dough containing lactic acid bacteria (2021-11-23),

8. 11130938 - Compositions comprising live probiotic bacterial cultures ofor (2021-09-28),

9. 11110136 - Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis (2021-09-07),

10. 11110135 - Bacterial strains belonging to the genusfor use in the treatment of hypercholesterolaemia (2021-09-07),

11. 11096975 - Compositions for use in the treatment of tumors resistant to chemotherapy (2021-08-24),

12. 11077153 - Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprisingLER03 and/orLS06 (2021-08-03),

13. 11026922 - Compositions comprising melatonin and flavonoids for use in the treatment of tumours resistant to chemotherapy (2021-06-08),

14. 10982184 - Bacterial strains capable of metabolizing oxalates (2021-04-20),

15. 10933105 - Composition for use as a support therapy for treatment of tumours, AIDS and leukaemia (2021-03-02),

Title: Innovations by Giovanni Mogna: A Trailblazer in Therapeutic Compositions

Introduction

Giovanni Mogna, based in Novara, Italy, is a prolific innovator with a remarkable portfolio of 31 patents. His contributions to the field of medical and pharmaceutical compositions have significantly advanced therapeutic options for various conditions, reflecting his dedication to improving health outcomes.

Latest Patents

Among his latest advancements is a composition aimed at treating major depressive disorder. This invention supports the improvement of mood disturbances and overall mood state. Additionally, Mogna has developed an innovative composition utilizing lactic bacteria to address infections caused by Propionibacterium acnes, targeting conditions such as acne, seborrheic dermatitis, rosacea, and eczema. His formulations are versatile, available in both oral and topical pharmaceutical forms, which include powders, tablets, creams, and gels, suitable for various applications.

Career Highlights

Giovanni Mogna has played an influential role in companies such as Probiotical S.p.A. and Probiotical North America Inc., where he has utilized his expertise to drive innovation in health-related products. His career is marked by a commitment to developing solutions that enhance quality of life.

Collaborations

Throughout his career, Mogna has collaborated with notable professionals, including Gian Paolo Strozzi and Luca Mogna. These partnerships have fostered an environment of creativity and innovation, allowing for the development of cutting-edge therapeutic compositions.

Conclusion

Giovanni Mogna's extensive patent portfolio and his contributions to therapeutic innovations underscore his role as a leader in the health and wellness sector. His work continues to pave the way for emerging treatments, showcasing the potential of innovation in addressing complex health challenges.

Profile summary based on public USPTO records.